Insider and congress filings

Colgate-Palmolive Company (CL)

NYSE · Consumer Defensive · 352 insider filings · 112 congress trades · last filed 7 days agoS&P 500

15
Open-market insider filings shown
2d
Median delay on the insider filings
within the two business day rule
0/15
Purchases and sales in the filings shown

About Colgate-Palmolive Company

from the company's filings and listing
Exchange
NYSE
Sector
Consumer Defensive
Industry
Household & Personal Products
Chief executive
Noel R. Wallace
Employees
33,600
Listed since
-
Market value
$70.4B
Price to earnings
34.6
Earnings per share
$2.56
Dividend yield
2.39%

www.colgatepalmolive.com

Earnings

6 reported quarters · next on Oct 30, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 31, 2026$0.99$0.95$5.4B$5.4BEPS beatRevenue in line
May 1, 2026$0.97$0.94$5.3B$5.2BEPS beatRevenue beat
Jan 30, 2026$0.95$0.91$5.2B$5.1BEPS beatRevenue beat
Q3 FY2025reported Oct 31, 2025$0.91$0.89$5.1B$5.1BEPS beatRevenue in line
Q2 FY2025reported Aug 1, 2025$0.92$0.90$5.1B$5.0BEPS beatRevenue in line
Q1 FY2025reported Apr 25, 2025$0.91$0.86$4.9B$4.9BEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Mar 25, 2026
ExecutiveSalaryStock awardsOtherTotal
Noel WallaceChairman, President and Chief Executive Officer$1.5M$8.0M$7.0M$16.5M
Shane GrantChief Operating Officer, Americas$592K$8.4M$2.9M$11.9M
Stanley J. Sutula IIIChief Financial Officer$1.1M$2.1M$2.5M$5.7M
Panagiotis TsourapasChief Operating Officer, Eur., APac, Afr/Eur, Skin and$1.0M$1.3M$1.8M$4.1M
Jennifer M. DanielsChief Legal Officer and Secretary$953K$1.3M$1.5M$3.8M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$6.4B69,915,472-3.8%8.78%
Vanguard Capital Management LLC$4.8B52,246,333+0.1%6.56%
State Street Corp$4.3B47,020,966-1.5%5.90%
Price T Rowe Associates Inc$2.6B27,909,525-17.3%3.50%
Vanguard Portfolio Management LLC$2.2B24,021,137+0.8%3.02%
Geode Capital Management, LLC$2.1B23,144,319+1.1%2.91%
Morgan Stanley$2.0B22,072,925+5.7%2.77%
Bank Of New York Mellon Corp$1.2B13,532,417+8.1%1.70%
Deutsche Bank Ag\$1.1B11,751,973-1.5%1.48%
Norges Bank$888.0M9,686,029+100.0%1.22%
Acadian Asset Management LLC$833.9M9,096,779+14.6%1.14%
FMR LLC$823.6M8,983,071-0.3%1.13%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next CL filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

15 filings of 352 on record
InsiderActionSharesPriceValueTrade dateDelay
Panagiotis TsourapasCOO, Cd, Emea, Apac, SkinSold10,000$92.05$920KAug 24, 20262d
John T. CahillDirectorSold4,170$93.37$389KAug 6, 20261d
Noel R. WallaceChairman, President & CEOSold161,021$92.52$14.9MAug 5, 20261d
Noel R. WallaceChairman, President & CEOSold161,021$91.92$14.8MAug 4, 20262d
Gregory MalcolmEVP and ControllerSold2,300$88.44$203KMay 15, 20263d
Sally MasseyChief People OfficerSold8,599$87.41$752KMay 7, 20264d
Panagiotis TsourapasCOO, Eur., Apac, Afr Eur, SkinSold15,000$97.81$1.5MFeb 12, 20261d
Panagiotis TsourapasCOO, Eur., Apac, Afr Eur, SkinSold35,000$94.61$3.3MFeb 11, 20262d
John HazlinChief Growth OfficerSold20,989$94.25$2.0MFeb 10, 20262d
Gregory MalcolmEVP and ControllerSold12,747$94.91$1.2MFeb 6, 20264d
Sally MasseyChief Human Resources OfficerSold15,851$95.03$1.5MFeb 5, 20264d
Noel R. WallaceChairman, President & CEOSold45,568$93.91$4.3MFeb 4, 20262d
Jennifer DanielsCLO and SecretarySold22,000$94.34$2.1MFeb 4, 20262d
Stanley J. Sutula IIIChief Financial OfficerSold97,843$94.27$9.2MFeb 4, 20262d
Sally MasseyChief Human Resources OfficerSold1,237$80.89$100KNov 21, 20253d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in CL

20 disclosures of 112 on record · median 28d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockSale$1,001 - $15,000-2.1%S&P +0.6% · vs S&P 500 -2.7%Aug 3, 2026Sep 4, 202632d
Kevin HernJointStockSale$1,001 - $15,000-3.1%S&P -0.8% · vs S&P 500 -2.3%Aug 19, 2026Sep 1, 202613d
Julie JohnsonJointFiled lateStockSale$1,001 - $15,000+9.8%S&P +14.6% · vs S&P 500 -4.8%Sep 23, 2025Aug 5, 2026316d
Julie JohnsonJointFiled lateStockPurchase$1,001 - $15,000+9.8%S&P +14.6% · vs S&P 500 -4.8%Sep 23, 2025Aug 5, 2026316d
Ro KhannaStockPurchase$1,001 - $15,000-0.3%S&P +0.4% · vs S&P 500 -0.6%Jun 2, 2026Jul 6, 202634d
Ro KhannaStockPurchase$1,001 - $15,000-3.6%S&P +1.6% · vs S&P 500 -5.1%May 27, 2026Jun 9, 202613d
Ro KhannaStockPurchase$1,001 - $15,000-0.1%S&P +3.2% · vs S&P 500 -3.3%May 15, 2026Jun 9, 202625d
Ro KhannaStockPurchase$1,001 - $15,000+6.1%S&P +9.9% · vs S&P 500 -3.7%Jan 13, 2026Feb 6, 202624d
Ro KhannaStockPurchase$1,001 - $15,000+17.4%S&P +11.6% · vs S&P 500 +5.9%Nov 3, 2025Dec 8, 202535d
Ro KhannaStockPurchase$15,001 - $50,000+12.2%S&P +11.9% · vs S&P 500 +0.3%Nov 10, 2025Dec 8, 202528d
Ro KhannaStockSale$1,001 - $15,000+11.3%S&P +13.9% · vs S&P 500 -2.6%Oct 7, 2025Nov 6, 202530d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+4.7%S&P +16.1% · vs S&P 500 -11.4%Sep 11, 2025Oct 22, 202541d
Rick LarsenStockSale$1,001 - $15,000+13.7%S&P +13.5% · vs S&P 500 +0.1%Oct 6, 2025Oct 16, 202510d
Tim MooreStockSale$1,001 - $15,000+5.8%S&P +17.1% · vs S&P 500 -11.2%Sep 10, 2025Oct 10, 202530d
Julie JohnsonJointStockSale$1,001 - $15,000+10.5%S&P +15.5% · vs S&P 500 -5.1%Sep 25, 2025Oct 7, 202512d
Ro KhannaStockSale$1,001 - $15,000+9.5%S&P +14.9% · vs S&P 500 -5.4%Sep 29, 2025Oct 3, 20254d
Ro KhannaStockPurchase$1,001 - $15,000+4.5%S&P +17.2% · vs S&P 500 -12.8%Sep 9, 2025Oct 3, 202524d
Ro KhannaStockPurchase$1,001 - $15,000+3.4%S&P +17.8% · vs S&P 500 -14.4%Sep 5, 2025Oct 3, 202528d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+2.0%S&P +18.4% · vs S&P 500 -16.4%Aug 13, 2025Sep 12, 202530d
Ro KhannaStockPurchase$1,001 - $15,000+4.6%S&P +18.2% · vs S&P 500 -13.6%Aug 26, 2025Sep 9, 202514d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

6 members · estimate, as of Sep 10, 2026

6 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Kevin HernRepublican · House$50,001 - $100,0000.3%
Gary C. PetersDemocrat · Senate$15,001 - $50,0000.8%
Gilbert Ray Cisneros, Jr.Democrat · House$1,001 - $15,000<0.1%
Randy FineRepublican · House$1,001 - $15,0000.5%
Robert BresnahanRepublican · House$1,001 - $15,0000.1%
Thomas H. Kean, Jr.Republican · House$1,001 - $15,0000.2%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
John T. CahillDirectorOption exercise4,170Aug 6, 2026
Noel R. WallaceChairman, President & CEOOption exercise161,021Aug 4, 2026
Noel R. WallaceChairman, President & CEOOption exercise161,021Aug 5, 2026
Brian NewmanDirectorStock award209Jul 1, 2026
Lorrie M. NorringtonDirectorStock award293Jul 1, 2026
John P. BilbreyDirectorStock award265Jul 1, 2026
Shane GrantCOO, AmericasTax withholding23,347Jun 16, 2026
Betsy FishboneCLO and SecretaryForm 461,808Jun 1, 2026
Martina HundmejeanDirectorStock award4,499May 11, 2026
John P. BilbreyDirectorStock award4,499May 11, 2026
Christopher S. BoernerDirectorStock award3,403May 11, 2026
John T. CahillDirectorStock award4,499May 11, 2026
Lisa EdwardsDirectorStock award4,499May 11, 2026
Lorrie M. NorringtonDirectorStock award4,499May 11, 2026
C. Martin HarrisDirectorStock award3,980May 11, 2026
Brian NewmanDirectorStock award4,499May 11, 2026
Kimberly A. NelsonDirectorStock award4,499May 11, 2026
John P. BilbreyDirectorStock award266Apr 1, 2026
Brian NewmanDirectorStock award210Apr 1, 2026
Lorrie M. NorringtonDirectorStock award294Apr 1, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling CL?

Across the 15 most recent open-market filings shown here, 0 were purchases and 15 were sales.

Which members of Congress have traded CL?

Ro Khanna, Kevin Hern, Julie Johnson, Lisa C. McClain, Rick Larsen, Tim Moore disclosed CL transactions in the filings shown here.

Which members of Congress hold CL?

6 members of Congress report a position in CL in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Kevin Hern, Gary C. Peters and Gilbert Ray Cisneros, Jr.. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is CL in the S&P 500 or the Nasdaq 100?

Colgate-Palmolive Company is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are CL trades disclosed?

Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track